MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cubist Pharmaceuticals Company Profile (NASDAQ:CBST)

Consensus Ratings for Cubist Pharmaceuticals (NASDAQ:CBST) (?)
Ratings Breakdown: 1 Sell Rating(s), 8 Hold Rating(s)
Consensus Rating:Hold (Score: 1.89)
Consensus Price Target: $90.17 (11.55% downside)

Analysts' Ratings History for Cubist Pharmaceuticals (NASDAQ:CBST)
Show:
DateFirmActionRatingPrice TargetActions
12/22/2014Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014GabelliDowngradeBuy -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014RBC CapitalDowngradeOutperform -> Sector Perform$84.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014MizuhoDowngradeBuy -> Neutral$97.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Jefferies GroupDowngradeBuy -> Hold$88.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseDowngradeOutperform -> Neutral$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014WedbushInitiated CoverageNeutral$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014SunTrustInitiated CoverageBuy$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014JMP SecuritiesDowngradeOutperform -> Market Perform$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014Jefferies GroupReiterated RatingBuy$87.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2014GabelliInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Leerink SwannBoost Price TargetOutperform$80.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2014Cantor FitzgeraldBoost Price Target$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2014MizuhoBoost Price TargetBuy$81.00 -> $97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014Credit SuisseReiterated RatingOutperform$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014AegisBoost Price TargetBuy$70.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014Cantor FitzgeraldBoost Price Target$65.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/24/2014MizuhoBoost Price TargetBuy$77.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2014Jefferies GroupBoost Price Target$82.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013RBC CapitalBoost Price TargetOutperform$78.00 -> $82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2013Cantor FitzgeraldBoost Price Target$63.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2013JMP SecuritiesInitiated CoverageOutperform$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Leerink SwannBoost Price Target$76.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Jefferies GroupBoost Price Target$76.00 -> $82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Morgan StanleyInitiated CoverageOverweight$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2013Cantor FitzgeraldLower Price TargetHold$72.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2013WedbushDowngradeOutperform -> Neutral$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2013Jefferies GroupReiterated RatingBuy -> In-Line$70.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2013AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2013OppenheimerInitiated CoverageOutperform$81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2013MizuhoUpgradeNeutral -> Buy$50.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/27/2013Cantor FitzgeraldBoost Price TargetHold$65.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2013Leerink SwannUpgradeMarket Perform -> Outperform$57.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013RBC CapitalBoost Price TargetOutperform$64.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha